UBS initiates Celgene Corporation(NASDAQ:CELG) with a Buy and price target of $140. Robust top-line growth has become a rarity in large-cap biotech, and against that backdrop, Celgene has and should continue to stand out

Celgene Corporation(NASDAQ:CELG) announces the formation of a consortium for the purpose of accelerating the discovery & development of cancer therapeutics/diagnostics, paid $50 mln in total to each institution for the option to enter into

Lakeway, NY — (MARKET NEWS CALL) — 19/02/2016— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues

Lakeway, NY — (MARKET NEWS CALL) — 10/02/2016— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues